ProQR Therapeutics (PRQR) Other Working Capital Changes (2013 - 2026)

ProQR Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$519060.5 in Q3 2025.

• Quarterly Other Working Capital Changes fell 4.11% year-over-year to -$519060.5 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$1.9 million (down 0.73% YoY) and the FY2021 annual result came in at -$970385.7, down 40.48% from the prior year.
• Other Working Capital Changes improved to -$519060.5 in Q3 2025 per PRQR's latest filing, from -$596418.5 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at -$16859.8 in Q2 2021 and troughed at -$704534.1 in Q2 2023.
• A 5-year average of -$426137.4 and a median of -$409212.7 in 2021 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 85.42% in 2021, down 127557.95% in 2021.
• Over 5 years, Other Working Capital Changes stood at -$255105.5 in 2021, then tumbled by 50.59% to -$384152.5 in 2022, then dropped by 22.42% to -$470271.1 in 2023, then dropped by 6.02% to -$498591.7 in 2024, then slipped by 4.11% to -$519060.5 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$519060.5, -$596418.5, and -$498591.7 for Q3 2025, Q1 2025, and Q3 2024 respectively.